Physician profile
Scott Mintzer
NPI 1811917933
$43,328.33
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $16K · 2021: $1,665 · 2022: $2,025 · 2023: $5,400 · 2024: $4,485.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $9,885.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $9,885.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $11,165.34 | 2020-2021 | |
| Ucb, INC. | $10,532.49 | 2019-2024 | |
| Biogen, INC. | $8,575.00 | 2019-2020 | |
| Ucb Sa | $3,750.00 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $3,750.00 | 2022-2024 | |
| Livanova USA, INC. | $2,555.50 | 2020 | |
| Jazz Pharmaceuticals INC. | $2,160.00 | 2024 | |
| Aquestive Therapeutics, INC. | $840.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mintzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.